CellCura ASA (FRA:C6L) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is CellCura ASA Asset Impairment Charge?

CellCura ASA's Asset Impairment Charge for the three months ended in Jun. 2014 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2014 was €0.00 Mil.

CellCura ASA Asset Impairment Charge Historical Data

The historical data trend for CellCura ASA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Asset Impairment Charge Chart

CellCura ASA Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Asset Impairment Charge

Get a 7-Day Free Trial

0.05

CellCura ASA Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

CellCura ASA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

CellCura ASA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

CellCura ASA (FRA:C6L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unionsgata 18, Skien, NOR, 3732

Website

http://www.cellcura.com

CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines